spacer
home > ict > autumn 2019 > a decentralised ecosystem
PUBLICATIONS
International Clinical Trials

A Decentralised Ecosystem





Digital disruption in clinical research has been a constant for over 20 years; however, ensuring that this is still relevant where ‘the rubber hits the road’ has been a challenge (or roadblock, sticking with the metaphor). Following my recent attendance at the annual conference of the Society of Clinical Data Managers, I believe the momentum is now greater, and there is an appetite for change. This change is to how and where we capture and analyse the valuable data that are provided by human subjects who volunteer to take part in clinical trials.

Of many presentations and panel discussions, there was so much enthusiasm from inquisitive minds in our industry. While the day-to-day work of clinical research is pressurised, the professionals and experts in our industry are determined to advance processes that can improve data quality, reduce the risks on clinical trials, and improve safety and outcomes for patients, while also working to increase efficiency through cost and cycle time reductions.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Ian O’Shaughnessy has over 22 years of experience in clinical research working at CROs. The first part of his career was spent in roles of increasing responsibility in clinical data management and programming. This included leading regional data management organisations for ICON in Europe and Asia Pacific. Since 2013, Ian has worked in the field of risk-based monitoring, developing ICON’s methodology, processes, and systems. He has worked directly with sponsor companies on early engagement and implementing risk-based clinical strategies. Ian holds a Bachelor’s in Genetics from Trinity College Dublin, Ireland, and postgraduate qualifications in Business, Management, and Information Technology.


Print this page
Send to a friend
Privacy statement
News and Press Releases

ADM Supports Clinical Trial into Effects of Probiotic Supplements for COVID-19 Patients in Hospital Care

ADM and Hospital de Sagunto, one of the largest medical centers in the Valencia region, today announce their partnership for a clinical trial into the effects of using a food supplement containing live microbial strains to promote gut microbiome balance and help improve health functions related to outcomes for COVID-19 patients in high-risk groups. On 18th March Dr Xavier Cortés, gastroenterologist at Hospital de Sagunto, communicated with medical staff in China who had observed that many COVID-19 patients had exhibited abnormal changes in their gut microbiome.
More info >>

White Papers

Streamlining patient recruitment using EHR data

The field of (bio)pharmaceutical research is booming. Increasingly more innovative therapeutics are being developed with the ability to drastically improve the quality of life of millions of patients around the world. Rigorously testing each of these candidate drugs for their safety and efficacy is an essential part of the development process. As the number of clinical trials steadily increases, the search for patients who present a specific medical profile and are willing to participate intensifies.
More info >>

 
Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement